Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
5.74
-0.56 (-8.89%)
At close: Dec 5, 2025, 4:00 PM EST
6.36
+0.62 (10.77%)
After-hours: Dec 5, 2025, 7:33 PM EST
Galectin Therapeutics Employees
Galectin Therapeutics had 15 employees as of December 31, 2024. The number of employees increased by 1 or 7.14% compared to the previous year.
Employees
15
Change (1Y)
1
Growth (1Y)
7.14%
Revenue / Employee
n/a
Profits / Employee
-$2,496,133
Market Cap
370.07M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
GALT News
- 2 days ago - Clinical Progress Drives Galectin Shares Up Post-NAVIGATE Data - Seeking Alpha
- 10 days ago - Galectin Therapeutics: NAVIGATE Data Validates The Fibrosis Thesis - Seeking Alpha
- 22 days ago - Galectin Therapeutics Reports Financial Results for the quarter ended September 30, 2025, and Provides Business Update - GlobeNewsWire
- 3 months ago - Galectin Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewsWire
- 7 months ago - Galectin Therapeutics Presented NAVIGATE Trial Results at the European Association for the Study of the Liver (EASL) 2025 Congress - GlobeNewsWire
- 8 months ago - Galectin Therapeutics Reports 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 11 months ago - Galectin Therapeutics to Present at the 2025 MASH-TAG Conference - GlobeNewsWire
- 1 year ago - Why Is Small Cap Galectin Therapeutics Stock Trading Lower On Friday? - Benzinga